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SUMMARY 
• Keratinocytes, a key cellular component for both ho-
meostasis and pathology of the skin, secrete a number of 
growth factors and cytokines, and their proliferation and 
differentiation are stimulated by a variety of biological 
factors. The major mechanism by which keratinocytes respond 
to extracellular signals is change in protein phospho-rylation. 
In this review, we focus on factors known to influence 
keratinocyte proliferation and differentiation, such as 
epidermal frowth factor family, nerve growth factor, 
transforming growth factor-fil, insulin-like growth factor-I, 
keratinocyte growth factor, hepatocyte growth factor, 
cytokines. A hypothesis for a dual role of epidermal frowth 
factor in keratinocyte proliferation and differentiation is 
proposed. (Biomed Rev 1997; 8: 73-85) 
INTRODUCTION 
• Cell proliferation plays a fundamental role in the 
development and maintenance of organisms. Keratinocytes, a 
key component for both homeostasis and pathology of the 
skin, secrete and are a target of various biological factors that 
influence their proliferation (Table 1). Endogenous for the 
keratinocyte factors inducing proliferation of these cells are 
epidermal growth factor (EOF), transforming growth factor-a 
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(TGF-a), nerve growth factor (NGF), basic fibroblast growth 
factor (bFGF), proopiomelanocortin (1), heparin-binding EGF-
like growth factor (HB-EGF) (2), amphiregulin (AR) (3), 
while transforming growth factor-(3 (TGF-(3) is a keratinocyte 
proliferation inhibitor. Endocrine regulation on keratinocyte 
proliferation is also performed, in both positive (androgens, 
corticotropin, bombesin, estrogens, glucocorticoids, insulin, 
neurokinins, placental extract, progestins) and negative 
(calcitriol, glucocorticoids, epinephrine, parathyroid 
hormone-related protein, vitamin A hormone) manner. 
Keratinocyte differentiation inducers are androgens, 
corticotropin, calcitriol, glucocorticoids, epinephrine, 
parathyroid hormone-related protein, vitamin A hormone, 
thyroxine (reviewed in 4). The basis for differential cell 
responsiveness to growth factors is complex, and results from 
the selective receptor expression on the cell surface, the tonic 
influence of other growth regulatory factors in the biological 
milieu, and the presence of intrinsic signalling or processing 
mechanisms. Disruption of these regulatory processes 
leads to absent (aplastic), inappropriate (metaplastic), or 
persistent (neoplastic) cell proliferation. 
EPIDERMAL GROWTH FACTOR FAMILY 
• EGF is a member of the family of EGF-like molecules, which 
also includes TGF-a, poxvirus growth factors, AR, epi-regulin, 
HB-EGF, and betacellulin, all encoded by separate genes. 
Normal epidermal proliferation and differentiation appear to 
be integrated and regulated structurally and functionally by a 
local production of TGF-a and a selective expression of its 
congate receptor, the EGF receptor, within the germinative 
layers of epidermis. By contrast, psoriasis is 
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associated with unbalanced proliferation and differentiation, 
evidenced by both enhanced expression of TGF-a and persistent 
expression of EGF receptor in the upper stratified layer of 
psoriasis epidermis (5). 
•        Epidermal growth factor 
EGF was the second growth factor to be discovered (Stanley 
Cohen, 1962) and purified, and is considered a prototype 
growth factor. It is one of the most thoroughly investigated 
peptide growth factors, and in many ways has been a model for 
revealing the biological andbiochemical mechanisms of growth 
control. EGF binds to its receptor, inducing receptor dimeri-
zation, activation of receptor tyrosine kinase activity, and 
autophosphorylation of multiple tyrosine residues in the cy-
toplasmic domain of the receptor (6). These residues, and 
surrounding amino acids serve as binding sites for the SH2 
domains of several proteins such as She (a prolin-rich adaptor 
protein), the p85 subunit of phosphatidylinositol 3' kinase, 
phospholipase C (PLC), and the protein tyrosine kinase Src. , 
The tyrosine phosphorylation site on She serves for binding of a 
praline-rich binding motif of the SOS exchange protein, 
leading to activation of Ras, which in turn binds to the Raf 
protein. Raf phosphorylates and activates the serine/threo-nine 
kinase MEK. Activated MEK phosphorylates and activates the 
mitogen-activated protein kinase (MAPK), which regulates 
multiple intracellular pathways involving transcrip-tional 
activation, cell proliferation, and cytoskeletal rearrangements (7). 
• Epidermal growth factor as a differentiation factor in 
keratinocytes 
EGF is a well known keratinocyte proliferation (8) and 
migration (9) factor. Our recent studies suggested that, in 
addition to these effects, EGF seems to play a role in 
epidermal differentiation. We demonstrated that in contrast 
to human dermal fibroblasts (10), EGF activated MAPK 
activity in 
human keratinocytes by a protein kinase C (PKC)-dependent 
pathway (11). This result was somewhat surprising, in view of 
the ability of PKC to control negatively human keratinocyte 
growth in response to EGF (12). In addition, evidence strongly 
supports the necessity of PKC activation in the initial signal 
ling events of keratinocyte differentiation (12-15). EGF can 
stimulate the transcription of the immediate-early response 
genes c-fos and c-jun (6). It has been shown that c-fos and c-jun, 
whose expression is controlled by PKC (13), are involved in 
the differentiation process of keratinocytes, rather than their 
proliferation (16). In addition, c-fos and c-jun expression (17) 
and PKC activity (18) are decreased in psoriasis. Thus, EGF, 
PKC, MAPK cascade, c-fos, and c-jun may play a role in human 
keratinocyte differentiation. Our results also suggest that 
MAPK (in our experimental conditions) is probably not in 
volved in triggering EGF-stimulated proliferation of keratino 
cytes. In support of this idea is the finding that pituitary extract 
(a commonly used mitogen for the serum-free culture of human 
keratinocytes) stimulated the proliferation of human keratino 
cyte cultures, while inhibited the basal MAPK activity. EGF 
was not able to stimulate proliferation, but stimulated MAPK 
activity. EGF also abrogated the stimulatory effect of the 
pituitary extract, restoring the MAPK stimulation (unpub 
lished results). 
The effects on keratinocyte growth or differentiation may be 
dependent on mitogen concentrations. In human keratinocytes, 
EGF at 25ng/mL, a concentration commonly used in cell 
cultures, did not stimulate but actually decreased the 
incorporation of 3H-thymidine into DNA, while EGF greatly 
enhanced the antiproliferative activity of 1,25 
dihydroxyvitamine D3 (1,25(OH)2D3) (19). In HN6 and HN30 
keratinocytes, EGF can stimulate or inhibit cell growth 
depending on its doses. p21 (WAF1/CIP1/SDI1) is a likely 
mediator of EGF-induced growth-inhibition, probably through 
mechanisms involving sequestration of the PCNA protein, and 
inhibition of cyclin-dependent kinase (CDK) activity (20). A 
biphasic DNA synthesis response to EGF and TGF-a has been 
observed. PKC down-regulation was also dependent on the 
growth factor concentrations (21). Bovine pituitary extract may 
have stimulatory or inhibitory effects on keratinocyte growth, 
depending upon its concentration as well as the presence of 
other components and their respective concentrations (22). 
The effects of the mitogens could be also dependent on the 
cell culture state. Thus, the direction of the proliferative 
response to 1,25(OH)2D3 in cultured human keratinocytes 
depends on the extracellular Ca2+ concentration and the degree of 
cell differentiation (23). In subconfluent human 
keratinocytes expressing basal cell phenotype, an autocrine 
growth factor of the EGF family suppressed the terminal 
differentiation (24). It is possible that in confluent andpostconfluent 
cultures, corresponding to a differentiation phenotype, EGF 
acts on   
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keratinocyte differentiation via a PKC-M APK dependent pathway 
(11), and the inhibition of this pathway leads to a stimulatory effect 
ofEGF on keratinocyte proliferation (12). Ourhypothesis was 
recently supported in papers showing that Ca
2
* increased TGF-
cdevels, which in turn stimulated tyrosine phosphorylation of the 
EOF receptor and PKC-8 during keratinocyte differentiation (25). 
Also, EOF supressed the expression of the suprabasal keratins 
(early markers of terminal differentiation), while enhancing 
involucrinandtransglutaminase(latemarkers)(26). 
•        Transforming growth factor-a 
TGF-a is synthesized in many human tissues and is structurally 
related to EGF. They are both highly homologous peptides 
with substantial solution structure similarity dependent on 
conserved cystein residues, and have an antigenic relationship to 
EGF as well as binding capacity to its receptor now called the 
EGF/TGF-a receptor (27). EGF and TGF-a affect cultured 
keratinocytes mainly by increasing their rate of migration (9). 
They may elicit divergent effects in certain biologi-   
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cal processes (TGF-cc was more effective thanEGF in promoting 
colony dispersion, in vitro wound closure, and single-cell 
migration), but retain similar responses in another context (EGF 
and TGF-a evoked identical profiles of DNA synthesis) (28). 
TGF-a induced interleukin-6 (IL-6) 
inapermanenthumankeratinocyte cell line (HaCaT) possibly by 
transcriptional activation of nuclear factor(NF)-KB, andNF-IL-6 
(29). Low basal levels of TGF-a but not of EGF are produced by 
keratinocytes and may contribute to the regulation of skin growth. 
TGF-ods likely to be an autocrine growth factor for normal human 
keratinocytes as well as for trans-formed cells. There is general 
agreementmat TGF-a isoverexpressed inthepsoriaticskin. 
Keratinocytes regulate production of TGF-a through a den 
sity-dependent mechanism (30). In human foreskin keratino 
cytes, a biphasic DNA synthesis response to EGF and TGF-a 
has been observed: low concentrations stimulated DNA syn 
thesis, while high levels (>3ng/mL) decreased DNA synthe 
sis. However, when keratinocytes were pretreated with PKC 
inhibitors, DNA synthesis remained elevated even at high 
growth factor concentrations (21). Vascular endothelial growth 
factor/vascular permeability factor (VEGF/VPF) plays a major 
role in diseases associated with increased vascular permeabil 
ity and angiogenesis. It is a 40-45 kDa glycosylated cytokine 
that potently and selectively enhances microvascular endo 
thelial cell proliferation and migration. Overexpression of 
VEGF is evident in many pathologic skin disorders, in particu 
lar psoriasis. TGF-a has been shown to induce VEGF expres 
sion in normal human epidermal keratinocytes in vitro (31). 
In normal human epidermal keratinocytes TGF-a activated the 
nucleartransription factors API, C/EBPp, andNFicB, while EGF 
activated API and NFKB, and bo vine calf serum -SP1 and API 
(32). 
a        Heparin-binding EGF-like growth factor 
HB-EGF belongs to the EGF family, and is an autocrine mito-
gen for keratinocytes that is overexpressed during wound 
healing and inflammatory processes. Low doses ultraviolet B 
(UVB), and H2O2 induce HB-EGF expression and keratino- 
cyte proliferation (2).          
•         Amphiregulin 
AR (initially called keratinocyte autocrine factor) is a hepa- 
rin-binding, heparin-inhibited member of the EGF family, the 
predominant autocrine growth factor for cultured human kera 
tinocytes. AR is specifically expressed during epidermal de 
velopment in utero, and has also been shown to be increased 
in psoriatic epidermis and other epidermal proliferative disor 
ders. In the skin of transgenic mouse whose epidermis is targetedto 




NERVE GROWTH FACTOR 
• NGF isknowntoinducegrowthofnervefibers,andplays 
acrucialrole in the development and maintenance of sensory and 
sympathetic neurons. NGF is synthesized in the skin and basal 
keratinocytes express the low-affinity nerve growth factor receptor 
(NGFR).Culturedhumanepidermalkeratinocytes synthesize and 
release NGF (33). NGF could act as a cytokine in human skin and 
take part in disorders ofkeratinocyte proliferation. It is known to be 
mitogenic for keratinocytes, anditseffectonkeratinocyteprolifera-
tion is mediated through the phosphorylation of its high-affinity 
tyrosinekinase receptor (trk). UVB can inhibit bothNGF synthesis 
and function in human keratinocytes (34). NGF has recently been 
shown to be overproduced by keratinocytes inpsoriasis, andmay be 
involved in the epidermal hyperplasia seen in this disorder, 
playing a pivotal role in the development and maintenance of 
psoriatic lesions (35). Normal human keratinocytes in culture 
express both the low- and high-affinity NGFR at mRNA level. 
NGF significantly stimulated the proliferation of normal human 
keratinocytes in culture in a dose-dependent manner, its effect 
mediatedby the high-affinity NGFR. Moreover, NGF mRNA was 
expressedinnormal human keratinocytes, and increasing amounts of 
NGF were secretedby keratinocytes during growth (3 6). NGF may 
play animportantrole in epidermal-dermal interactions, rein-
nervation, and reepithelisation occuring in wound healing and 
psoriasis, aT-cell mediated disease with intrinsic wound healing 
phenotype(77). 
Despite the fact that several cell types residing permanently or 
transiently in the skin, are sources and/or targets of NGF, little 
is known about the role of NGF in skin development, 
physiology and disease. 10-200 ng/mL of NGF stimulated 
epidermal keratinocyte proliferation in organ-cultured C57 BL-6 
mouse skin in the telogen phase of the hair cycle. Follicle 
keratinocyte proliferation was stimulated by 100 ng/mL NGF in 
telogen skin organ culture, but this concentration inhibited 
both epidermal and follicle keratinocyte proliferation in organ 
culture of anagen skin (38). 
TRANSFORMING GROWTH FACTOR-ftl 
• TGF-P superfamily comprises a broad variety of poly-
peptides with multiple biologic activities: TGF- (31-5, bone mor-
phogenic proteins, decapentaplegic, Vg 1, mullerian-inhibiting 
substance as well as activins and inhibins. TGF-p increases 
proliferation of dermal fibroblasts and stimulates deposition of 
extracellular matrix molecules and integrins by these cells. By contrast, 
it inhibitits proliferation of keratinocytes, and induces their 
differentiation. TGF-J3 is secretedby most cultured cells in an inactive 
(latent) form, converted to the active polypeptide by proteases. The 
binding of the latent polypeptide to a mannose-6-phosphate 
receptor facilitates the activation of TGF-P by proteases, 
including plasmin and cathepsin. Once activated, TGF-P binds 
to a transmembrane   
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serine/threonine kinase receptor (type I or type II), responsible for 
signal transduction. TGF-p 1 (a homodimeric 25 kDaprotein) is 
known to inhibit epithelial cell growth by inducing a G1 cell cycle 
arrest, and suppression of c-myc transcription has been implicated in 
the mechanism ofTGF-pl inhibition ofkeratinocytegrowth(39). 
Treatment of early passage human keratinocytes and HaCaT cells 
with TGF-P1 resulted in formation of a DNA binding complex 
between theretinoblastomasusceptibility(Rb)-relatedproteinpl30 
andE2F. This correlated with inhibition of cell cycle progression at 
G1, and suppression of the E2F-regulated cdc2 gene, p 130 is a 
downstream target of TGF-p 1 and apossible mediator of the G1 -
airest(40). Thetranscriptional suppression of c-myc is important in 
the TGF-p 1 growth inhibition pathway. The inhibition of B-myb 
and cyclin A (growth factor-inducible products that are critical 
regulators of G1 /S transition) may contribute to the late G1 -arrest 
causedbyTGF-pl. Theseeventsmaybelinkedthroughtheactions of 
Rb or a Rb family member (41). 
Normal progression through Gl is promoted by the activity of 
CDK4 and CDK6, which are inhibited by the protein p 16INK4. 
p!5INK4B is a new member of the p!6INK4 family, and its 
expression is induced approximately 30-fold in human 
keratinocytes after treatment with TGF-P 1, suggesting that 
pi5 may act as an effector of TGF-P 1-mediated cell cycle 
arrest. The gene encoding pi5 is located on chromosome 9 
adjacent to the pi 6 gene, at a frequent site of chromosomal 
abnormality in human tumors (9p21) (42). The inhibition of 
human keratinocyte growth by 1,25(OH)2D3) is associated 
with a time- and dose-dependent increase in the 
concentrations of TGF-P2 but not TGF-pl (43). 
INSULIN-LIKE GROWTH FACTOR-1 
• Insulin-like growth factor-I (IGF-I) is a single chain 
polypeptide of 70 amino acids that belongs to insulin-related 
proteins, which also include IGF-II, insulin, and relaxin. It is a 
primary mediator of growth hormone action, produced by 
many tissues as an autocrine/paracrine regulator of local 
tissue events. In the skin, IGF-Iis amajorkeratinocytemitogen, 
which also augments the mitogenic effects of EOF. It is 
produced by melanocytes and fibroblasts but not by 
keratinocytes, suggesting that it may be a paracrine regulator of 
keratinocyte proliferation. In the epidermis, the IGF-I receptor is 
expressed predominantly by basal keratinocytes, while in 
psoriasis expression is increased and also found in suprabasal 
keratinocytes. However, IGF-I alone is not sufficient for 
keratinocyte growth, requiring also EGF and bovine pituitary 
extract added (44). 
NEU DIFFERENTIATION FACTORS 
• The family ofNeu differentiation factors (NDF or heregulins) 
includes several glycoproteins, whose receptor binding domain 
displays two variants, a and p, which bind two receptor tyrosine 
kinases, ErbB-3 and ErbB-4. Different NDF isoforms induce 
distinct growth regulatory effects on cultured keratinocytes via 
direct activation of ErbB-3. Certain isoforms were reported to 
induce growth arrest and differentiation of mammary tumor cells, 
whileother breast cancer cell lines respondedmitogenically. Normal 
EGF-dependent epithelial cells, Balb/MKkeratinocytes, can 
undergo eitherproliferation or differentiation inresponse to various 
NDF isoforms. p Isoforms ofNDF had mitogenic effect, which was 
significantly weakerthan the maximal response to EGF. By 
contrast, ocNDF isoforms exerted almost no mitogenic activity, 
but were sufficient to maintain keratinocytes in culture (45). 
KERATINOCYTE GROWTH FACTOR 
• Keratinocyte growth factor (KGF) is a paracrine factor 
secreted by fibroblasts that stimulates keratinocyte growth. It 
belongs to the FGF family. The paracrine effect of KGF on 
epithelial cells is due to an alternative splicing variant of the 
FGF receptor-2, which can bind KGF or acidic FGF (aFGF) 
(12). In monolayer cultures, KGF expression by quiescent 
fibroblasts was stimulated by serum, EGF, and bFGF. 
However, in dermal equivalents, the collagen matrix 
negatively modulated KGF mRNA expression, and then only 
the serum slightly stimulated KGF expression. The induction 
of KGF gene was mediated by at least 2 different signalling 
pathways, involving PKC and cyclic adenosine monophosphate 
(cAMP) (46). In subconfluent keratinocytes, KGF did not 
show any significant increase of proliferation compared to 
EGF. However, at confluency, KGF stimulated keratinocyte 
proliferation stronglier than EGF. At higher concentrations, EGF 
showed greater potency than KGF (47). 
HEPATOCYTE GROWTH FACTOR 
• Hepatocyte growth factor/scatter factor (HGF/SF) has also 
been reported to promote keratinocyte migration and 
proliferation. It is a heterodimer composed of a 69 kDa oc-
chain and a 34 kDa p-chain and was originally identified as a 
potent mitogen for hepatocytes, but now is thought to be a 
pleiotropic factor acting as mitogen, motogen, and morphogen 
for various epithelial cells. HGF is produced by dermal 
fibroblasts, and its c-Met receptor (a transmembrane protein 
tyrosine kinase) is expressed by basal keratinocytes in wounded 
skin (48). HGF can stimulate keratinocyte collagenase-1 and 
stromelysin-1 production in a dose- and matrix-dependent 
manner. The regulation of collagenase-1 expression is trans-
criptionally mediated, and requires tyrosine kinase and PKC 
activities (49). In mouse keratinocytes (PAM-212), HGF and 
EGF, both potent mitogens for these cells, stimulated the 
DNA synthesis and tyrosine phosphorylation of MAPK (48). 
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• Cytokinesare 10-50kDaproteinmoleculeswhichexert 
regulatory effects on a variety of cell types, including immune cells. 
Inflammatory cytokines produced by keratinocytes are IL-1 a, IL- 
1 (3, IL-3, IL-6, IL-8, granulocyte colony-stimulating factor (G- 
CSF), macrophage colony-stimulating factor (M-CSF),granulocyte- 
macrophage colony-stimulatingfactor (GM-CSF), hepatocyte stimu 
lating factor III, tumornecrosis factor-a(TNF-a). IL-1 stimulates 
keratinocyte proliferation and chemotaxis, while IL-3, IL-6, and 
GM-CSF are autocrine growth factors for keratinocytes. The 
epidermis is also affectedby products of activated T-cells, com 
prising a large deal of the infiltrates seen in dermatoses; one such 
product, interferon (IFN)-y, is an importantnegative growthregu- 
lator of keratinocyte proliferation. IL-1, IL-3, and GM-CSF are 
alsoactivatedT-cellproducts(l).  
Upon stimulation, keratinocytes produce a range of cytokines 
including IL-6, IL-8, TGF-a, and GM-CSF. IL-6, IL-8, and 
TGF-a stimulate keratinocyte proliferation. The psoriatic 
keratinocytes were as responsive as normal keratinocytes to 
the stimulatory effects of TGF-a and IL-8, but were less 
susceptible to stimulation by IL-6, and both normal and 
psoriatic keratinocytes were generally unresponsive to GM-
CSF (49). The proliferative effects of IL-6 were mediated 
indirectly via the EGF/TGF-a receptor, and autocrine 
overexpression of IL-6 may be limited in psoriatic 
keratinocytes (50). These findings suggest that IL-6 is not a 
major autocrine mitogen for psoriatic keratinocytes (51). 
IL-4 is known as a cytokine playing a central role in the 
regulation of immune response. Two cytoplasmic proteins, 
STAT6 and IL-4-induced phosphotyrosine substrate/insulin 
receptor substrate! (4PS/IRS2), are activated in IL-4 signal 
transduc-tion. STAT6 has also been demonstrated to be 
important for effects of IL-13 related to IL-4 (52). IL-4 
stimulated the keratinocyte proliferation in vitro by inducing c-
myc expression (53). 
Increased expression of IL-6 and IL-8 may indicate transbasal 
cell carcinoma cell lineormation of normal keratinocytes in 
locally aggressive basal cell carcinoma (54). IL-8 is a potent 
proinflammatory molecule present in high amounts in psoriatic 
skin. There, it may play an important role in the keratinocyte 
hyperproliferation, and the neutrophil and T-cell infiltration 
associated with the disease. IL-8 synthesis may be regulated 
by PKC either positively (by phorbol 12-myristate 13-ac-
etate) or negatively (by IL-1J3 or TNF-a) (55). 
IFN represent a family of polypeptides with antiviral activity 
initially subdivided on the basis of their cellular source, IFN-oc 
secreted mainly by leukocytes, IFN-J3 - by fibroblasts, and 
IFN-y- by T-cells. IFN-oc/P are also synthesized and secreted 
by human keratinocytes, and may be involved in host defence 
mechanisms. UVB irradiation, IL-1 a, TNF-a, and lipopolysac-
charide increased IFN-oc/P mRNA expression in human 
keratinocytes (56). IFN-7 is a potent inducer of squamous 
differentiation in normal human epidermal keratinocytes, its 
effect characterized by a 95% or more decrease in the 
expression of two growth regulatory genes, cdc2 and E2F-1, 
and a 7-15-fold increase in the expression of two squamous 
cell-specific genes, TGase-1 and cornifm. It was hypothesised 
that in normal human epidermal keratinocytes, an 
irreversible growth arrest precedes the expression of the 
squamous-differentiated phenotype. The action of IFN-y on the 
expression of squamous cell-specific genes was antagonized 
by retinoic acid and TGF-P1. Both factors are potent 
suppressors of TGase-1/cornifm induction; however, they did 
not prevent the commitment to irreversible growth arrest (57). 
Activated T-cells produced INF-y (58), which activated 
sphingomyelin hydrolysis in keratinocytes, thus generating 
ceramide, which may function as a cytokine second messenger 
in keratinocytes 
(59). The induction of inducible nitric oxide synthase (iNOS) 
by INF-7 in human keratinocytes was differentiation-
dependent. This effect was antagonized by INF-oc, the latter 
also inducing growth arrest but not differentiation in these 
cells 
(60). IFN-y markedly increased the expression of mRNA of 
Fas (a cell membrane protein known to mediate apoptosis) in 
SV40-transformed human keratinocytes, thus inducing a Fas-
dependent programmed cell death in these cells, augmented 
by 12-0-tetradecanoyl-phorbol-13-acetate (TPA) via activation 
of PKC (61). 
MACROPHAGE-STIMULATING PROTEIN 
• Macrophage-stimulatingprotein(MSP)wasoriginallyiden- 
tified as an inducer of murine peritoneal macrophage responsive- 
ness to chemoattractants. It is structurally related to HGF and 
plasminogen. The product of RON, a protein tyrosine kinase 
cloned from a human keratinocyte library, is the MSP receptor, 
expressedby keratinocytes (62).  
PARATHYROID HORMONE-RELATED PROTEIN FRAGMENT 
• Low concentrations of the C-terminal parathyroid hormone-
related protein (PTHrP) fragments, PTHrP 107-111 and PTHrP 
107-139, stimulated membrane-associated PKC, but not adenylate 
cyclase or an internal Ca2  ̂ surge, in early passage human and 
BALB/MK-2 murine keratinocytes. The maximally PKC-
stimulating concentrations ofPTHrP 107-111 stopped or stimulated 
BALB/MK-2 keratinocyte proliferation depending on whether the 
cells were, respectively, cycling or quiescent at the time of 
exposure(63). 
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BRADYKININ 
• Kinins are potent vasoactive oligopeptides thatmay act as 
mediators in a variety of inflammatory skin diseases. The 
mammalian bradykinin is produced as a cleavage product by the 
action of kallikrein-like enzymes at sites of inflammation and injury, 
and causes pain, vasodilation, and smooth muscle contraction. Like 
the neuropeptides bombesin, vasopressin, and endothelin, ithas 
been reported to act as a growth factor, and implicated in 
various physiological andpathological conditions. Bradykinin is one 
of the key mediators of inflammation, and a weak mitogen. In a 
human keratinocyte cell line (HaCaT),bradykinin promoted 
expression of the proto-oncogenes c-fos, c-jun, and c-myc, but 
this did not correlate with cell proliferation (64). Bradykinin 
induced the generation of inositol 1,4,5-trisphosphate, which caused 
Ca2+ mobilization negatively modulated by PKC in primary 
cultured human keratinocytes (65). Stimulation of its receptor led to 
activation of a tyrosine kinase activity through a PKC-dependent 
pathway (66). 
WEUROPEPTIDES 
• Brain hormones may directly regulate skin functions. It was 
recently postulated that prolactin from anterior pituitary acts as 
a neuroendocrine modulator of skin epithelial cell proliferation 
carrying signals between the brain and the skin (67). 
Physiological concentrations of prolactin markedly 
stimulated the proliferation of newborn foreskin 
keratinocytes in serum-free medium (68). Dermal fibroblasts 
could be a potential local source of prolactin in the skin (69). 
Growth hormone receptors have been demonstrated in the 
epidermis, suggesting that keratinocyte proliferation could be 
also under control of this hormone (4). Unmyelinated cutaneus 
C-fibers secrete neurokinins of the tachykinin family, such as 
substance P and substance K, which were also found to 
promote keratinocyte growth (4). 
GUT HORMONES 
• Neuropeptides of gastrointestinal tract, termed gut 
hormones, have also been found in human skin. Vasoactive 
intestinal polypeptide stimulated cell proliferation and ade-
nylate cyclase activity (70), while bombesin increased thymi-
dme incorporation by cultured keratinocytes (71). Insulin, the 
only endocrine hormone absolutely required for support of 
keratinocyte proliferation, transmodulated EGF receptor 
expression in a dose-dependent manner without altering EGF-
binding activity (72). 
1.25-DIHYDROXYVITAMIN D 
• 1,25(OH)2D3 has been proposed as aphysiologic regulator 
ofkeratinocyte growth and differentiation. Ithas abiphasic effecton 
human keratinocyte growth. In medium free of serum, sterol, and 
pituitary extract, 1,25(OH)2D3 inhibited keratinocyte growth at 
concentrations greater than 10"8 M whereas it stimulated growth of 
these cells at concentrations lower than 10"9. In serum-containing 
medium, the hormone inhibitedkeratinocyte growth at all 
concentrations, effect associated with a decrease in C.-myc 
mRNA. Increased PKC activity and translocation of this enzyme 
to the plasmalemmahavebeenreported. The growth-inhibitory 
effectof 1,25(OH)2D3 involved, at least in part, an increase in 
TGF-|32 release (43). 
Physiological concentrations of 1,25(OH)2D3 are required 
for optimal mouse keratinocyte growth. In proliferative serum-
free culture system, physiological (picomolar) 
concentrations of this hormone stimulated proliferation of 
primary mouse epidermal keratinocytes, while at higher 
(nanomolar to micromolar) doses, growth was inhibited. The 
response to 1,25(OH)2D3 was mediated by a slow transduction 
pathway, such as that activated by its intracellular receptor 
(73). The effects of 1,25(OH)2D3 in cultured human 
keratinocytes depended also on the extracellular Ca2T 
concentration, and the stage of differentiation (23). 1,25(OH)2D3 
(10'12 M to 10'8 M) caused a dose-dependent increase of PKC 
activity in the so-lubilized membrane fractions of cultured 
human keratinocytes, and in the cytosolic fractions of cultured 
human fibroblasts (74). 1,25(OH)2D3 stimulated DNA 
synthesis via sequential activation of Raf and MAPK (75). 
PROSTAGLANDIN E 
• Prostaglandins (PG) are lipid-soluble hormone-like com 
pounds that bind to cell-surface receptors. They are synthesized 
from arachidonic acid, and at least 16 different PG in nine different 
chemical classes, designated PGA-PGI, are recognized. Four 
different genes encoding heterotrimeric G-protein linked PGE 
receptors have recently been cloned. The receptors are linked to 
stimulatory and inhibitory cAMP andphosphatidylinositol second 
messengerpathways. Ligands forEP2, EP4, and EP3c receptors 
were detected in non-confluent keratinocytes. EP3c-mediated 
signalling decreased cAMP, while EP2 and EP4 increased it. 
Growth of non-confluent keratinocytes was inhibited in 50% by 
treatment with indomethacin, and restored after addition of PGE2 
(but not other PG), which propably acted through the EP2 receptor 
(76). 
EICOSAPENTAENOIC ACID 
• Eicosapentaenoic acid (EPA) is a 20-carbonpolyunsatu-rated 
fatty acid that is structurally very similar to arachidonic acid. 
Itisfoundalmost exclusively inmarinefish oil. EPAhasaninhibitory 
effect on the human keratinocyte growth in vitro. Psoriasis is rare 
among Greenland Eskimos who eat EP A-rich diets, indicating that 
EPA may exert a protective effect against this disease (77). 
  
79 




• Thapsigargin, a sesquiterpene lactone, is the constituent of the plant 
Thapsiagarganica responsible for its potent skin- irritating effect. 
Thapsigarginhas demonstrated tumor-promoting activity in a two-
stage model of skin carcinogenesis, andbecause it did not bind or 
activate PKC, the compound has been classified as anon-TPAtype 
turn or promoter. Thapsigargin activates cells via arapid and very 
marked increase of intracellular free Ca2~ concentration ([Ca2~].) by 
intracellular stores, without hydrolysis of phospho-inositides. This 
is due to a specific inhibition of the endoplasmatic reticulum 
ATPase, which tips the equilibrium in favour of Ca2+ release from 
this intracellular store. Acute thapsigargin-induced [Ca2~], 
elevation inhibitedkeratinocyteproliferation, possibly due to 
induction ofc-fos and inhibition of protein synthesis. In contrast, 
sustained elevation of [Ca2+]. in response to thapsigargin was 
associated with increased keratinocyte proliferation in vitro and 
may, at least in part, mediate thapsigargin-induced epidermal 
hyperplasia and tumor promotion in vivo (78). 
LYSOPHOSPHATIDIC ACID 
• Lysophosphatidic acid(LPA) is abiologically active phos- 
pholipid known to have growth factor-like activity on fibroblasts. 
The effects of LPA are comparable with all-trans-retinoic acid 
(RA), a structurally unrelated lipid that has been previously shown 
to induce both TGF-oc and TGF-J3, andhas pronounced effects on 
keratinocyte proliferation and differentiation. Treatment of cultured 
human keratinocytes with LPA or RA elevated TGF-oc production 
4-8-fold. A number of structurally related phospholipids did not 
mimic the TGF-oc-inducing activity of LPA. LPA is mitogenic for 
keratinocytes, and its stimulatory effect could be blocked with an 
antibody to the EGFATGF-areceptor, suggesting that LPA-stimu- 
lated keratinocyte proliferation is mediated by TGF-oc. LPA and 
RA also induced both the active and latent forms of TGF-p in 
cultured keratinocytes. TGF-P induction may mediate the 
LPA effects on keratinocyte differentiation, namely inhibi 
tion of proliferation (confluent cultures) and increased involu- 
crin synthesis. Also, after LPA treatment, dramatic morpho 
logical changes were observed. Mechanistic studies suggested 
that LPA activates both pertussis toxin-sensitive and insensi 
tive signalling pathways involving PKC activation and protein 
tyrosine phosphorylation. The effects of LPA on TGF-a and 
TGF-P production by keratinocytes likely have in vivo rele 
vance as concluded from rodent studies with topical LPA 
treatment (79).  
TUMOR NECROSIS FACTOR-PC 
• Tumor necrosis factor-a (TNF-a) was found to induce certain 
keratinocyte differentiation products, including plas-minogen 
activator-inhibitor type 2 (PAI-2), which plays a role 
in keratinocyte terminal differentiation. PAI-2 is synthesized 
in high amounts in the superficial layers of normal human 
epidermis, and is concentrated along the periphery of 
keratinocytes in the granular layer. In cultured human 
keratinocytes, PAI-2 was induced by elevated Ca2" 
concentration, promoting a more differentiated epidermal 
phenotype. TNF-a increased PAI-2 mRNA and protein in 
keratinocytes incubated in both low Ca2+ medium (in which most 
cells have a basal-like phenotype) and high Ca2T medium (in 
which cells stratify and express various differentiation makers) 
(80). 
PLATELET-ACTIVATING FACTOR 
• Platelet-activating factor (PAF) is apotent lipid mediator 
involved in inflammation which interacts with a specific receptor. 
Cultured keratinocytes and fibroblasts were reported to produce 
PAF, and the PAF receptor is constitutively expressed in the 
epidermis. When PAF (0-1 OOnM) was added to human keratinocyte 
cultures, cell proliferation was inhibited dose-dependently, effect 
recovered by a PAF antagonist, WEB2086 (81). 
GAMGLIOSIDES 
• The alteredpatterns of ganglioside expression during density-
dependent growth inhibition, oncogenic transformation, and 
embryogenesis suggest that gangliosides, sialylatedmembrane gly-
colipids, may influence cell proliferation and differentiation. 
Gangliosides of the "b" synthetic pathway, including GM3, GD3, 
and GD1 b, inhibit the proliferation of cultured keratinocytes 
without affecting differentiation. In contrast, significant 
induction of keratinocyte differentiation by GTlb (a more 
highly sialylated ganglioside of the "b" synthetic pathway that is 
also present in cultured keratinocytes) has been noted, as 
evidenced by early desmosome formation, increased cornified 
envelope formation, and expression of involucrin and the 
differentiation-specific keratin Kl. The addition of GT1 b did not 
cause a shift in [Ca2"]. or affect PKC activity. Thus, alterations in the 
membrane concentration of GT Ib, a minor ganglioside component 
of the keratinocyte membrane, may modulate keratinocyte 
differentiation (82). 
CATECHOLAMINES 
• Human epidermis has capacity of total catecholamine 
biosynthesis. Catecholamine biosynthesis depends on the 
substrate supply (i.e. L-tyrosine), and an essential cofactor for 
tyrosine hydroxylase and phenylalanine hydroxylase (6R 
5,6,7,8 tetrahydrobiopterin). In the epidermis, epinephrine leads to 
in vivo expression of ahigh density of p2-
adrenoreceptorsinkeratinocytes. Upon adrenergic stimulation with 
epinephrine, a significant increase of both [Ca2*]. and cAMP 
occurred. Further, a connection has been demonstrated between 
catecholamine biosynthesis, p2-adrenoreceptor expression, Ca2+ 
flux, and the differentiation of keratinocytes inhuman epidermis 
(83).   
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ADENOSINE AND ADENINE HUCLEOTIDES 
• Adeninenucleosidesandnucleotidescanregulateavariety 
ofphysiological processes, including inhibition of cellproliferation, 
and immune cell function. They may be important regulators of 
keratinocyte growth in vivo. Adenosine and adenine nucleotides 
abrogate exogenous EGF-dependent or independent keratinocyte 
proliferation at submillimolar concentrations. Such compounds may 
find an application in the treatment of epidermal proliferative 
disorders, in which the EGF receptor signalling pathway is 
overactivated(84). Adenosine, adenosinemonophosphate, ad-
enosine diphosphate, and adenosine triphosphate may be released 
into the extracellular space at sites of tissue destruction by the 
disrupted cells, or at sites of inflammation by eosinophils and 
neutrophils. Transport of adenosine (or adenosine enzymatically-
derived from adenine nucleotides) into keratinocytes severely limits 
their ability to produce cytokines (IL-la, IL-8) in response to 
phorbol ester or TNF-oc stimulation (85). 
H202 UVB, THALIDOMIDE 
• UVB and H2O2 induce HB-EGF expression, and thus 
keratinocyte proliferation (2), EGF receptor phosphorylation 
(86), and TGF-p-inducible early gene expression (87). Tha-
lidomide is a powerful therapeutic agent for pyoderma gan-
grenosum and other skin wounds. It modulated human 
keratinocyte proliferation via a chemokine-dependent 
pathway, stimulating secretion of IL-8 known to increase 
human keratinocyte proliferation and migration ( 
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